Abstract:Purpose: Aberrant hedgehog (Hh) signaling has been reported in various cancers including breast cancers and clinical trials targeting this pathway are currently ongoing. Preclinical evidence suggests that increased ligand-dependent Hh signaling in breast tumor epithelial (E) cells cross-talks and activates Hh pathway in the stroma (S) but the clinical implication of this E/S interaction is unknown. We sought to determine the expression of Hh proteins in the E and S compartments of primary breast tumor samples and correlate with clinical outcomes. Methods: Using tissue microarray (TMA) of ∼500 primary breast cancer samples (OSU 2009C009 A) that includes both primary breast tumor and axillary metastasis, the expression pattern of the key Hh signaling proteins (Shh, Gli-1, SMO, Ptch1) and a target gene of the pathway (BMI1) was determined by immunohistochemistry (IHC) in both the epithelial and stromal tissues and compared to other known prognostic/predictive markers such as age, stage, estrogen/progesterone receptor (ER/PR)/HER2 status and to disease-free survival (DFS). IHC was performed using Benchmark LT automated system from Ventana Medical Systems using previously published methods (Nuovo GJ, Nature protocols, 2009). Scoring was done by combining the intensity and percentage of cells staining with respective antibodies by three independent measurements. Results: Analysis of a total of 315 primary breast tumors revealed the following percentage of tumors with high expression of Hh proteins in the E/S compartments respectively: Shh (72/31%), Gli-1 (69/53%), SMO (40/64%), and Ptch-1 (93/74%). Analyzing the interaction between the epithelial and stromal expressions of these proteins, we found positive correlation between i) high Shh and SMO in the epithelial cells and Gli-1 in the stroma, and ii) high Gli-1 in the epithelial cells and target protein Bmi1 in the stroma. High intensity staining of Gli-1 in the tumor epithelial cells was significantly associated with higher stage, grade, ER negative status and worse DFS. Adjusting for stage and ER status, tumors with increased epithelial Gli-1 expression was still significantly associated with worse DFS (p=0.0131, survival analysis) when compared to tumors with low expression. In particular, among the ER negative and node positive patients higher Gli-1 expression in epithelial cells was very significantly associated with poor DFS (p= Conclusions: We report here for the first time a positive correlation between expression of Hh proteins in the stromal and epithelial compartment of primary breast tumors. Furthermore, we observed that higher Gli-1 expression in the tumor epithelial cells was associated with worse DFS, particularly in the ER negative, node-positive tumors suggesting that aberrant Hh signaling may contribute to drug-resistance and hence a rationale therapeutic target. Further correlative studies between clinical parameters and additional Hh target genes in these tumors are in progress. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr S6-9.

Prognostic value of hedgehog signal component expressions in hepatoblastoma patients

Activation of Sonic Hedgehog Signaling Pathway is an Independent Potential Prognosis Predictor in Human Hepatocellular Carcinoma Patients

[Expression of Genes Related to Sonic Hedgehog Signaling in Human Hepatocellular Carcinomas].

Comprehensive Analysis of the Role of Hedgehog Signaling and Prognostic Significance in Human Pancreatic Cancer

Hedgehog Signaling in Human Hepatocellular Carcinoma

Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma

Screening hypoxia-related genes as prognostic biomarkers and modeling the individualized prognostic predictor in hepatocellular carcinoma

The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma

Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome

Activation of Hedgehog Signaling Pathway in Human Non-small Cell Lung Cancers

Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors

The prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics

Hedgehog signaling pathway activation in hepatocellular carcinoma

Expression of Hedgehog Signaling Molecules in Lung Cancer.

Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.

Identification of Hedgehog Signaling As a Potential Oncogenic Driver in an Aggressive Subclass of Human Hepatocellular Carcinoma: A Reanalysis of the TCGA Cohort.

Expression and Prognostic Value of Sonic Hedgehog in Hepatocellular Carcinoma

Expression and Regulation of Hedgehog Signaling Pathway in Pancreatic Cancer

The Pyroptosis Related Genes Signature Predicts Prognosis and Immune Infiltration of Tumor microenvironment in Hepatocellular carcinoma

Expression Of Hedgehog Proteins In The Epithelial And Stromal Compartments Of Primary Breast Tumors And Its Prognostic Significance

Activation of the Hedgehog Pathway in Human Hepatocellular Carcinomas